Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 1/20 | 0.38 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.38 |
| ▸ | GSTM2 | P28161 | 1/20 | 0.38 |
| ▸ | DGKA | P23743 | 1/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.36 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | KDM6B | O15054 | 1/20 | 0.35 |
| ▸ | KDM5C | P41229 | 1/20 | 0.35 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.35 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.35 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.35 |
| ▸ | PAM | P19021 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | NAAA | Q02083 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL176417 | 0.93 | DGKA (0.42) | HTR2CDGKAADRA2AADRA1AMAPT | |
| SCHEMBL29028494 | 0.86 | HTR2C (0.47) | HTR2CDGKAADRA2AADRA1AMAPT | |
| SCHEMBL6267406 | 0.86 | DGKA (0.44) | HTR2CDGKAADRA2AADRA1AMAPT | |
| SCHEMBL28289669 | 0.86 | HTR2C (0.47) | HTR2CDGKAADRA2AADRA1AMAPT | |
| SCHEMBL767599 | 0.85 | HTR2C (0.37) | HTR2CDGKAADRA2AADRA1AMAPT | |
| SCHEMBL27841157 | 0.85 | LTA4H (0.39) | HTR2CGSTP1GSTM2DGKAADRA2A | |
| SCHEMBL8839165 | 0.85 | DGKA (0.52) | HTR2CDGKAMAPTPAMNAAA | |
| SCHEMBL9323709 | 0.85 | GAA (0.38) | DGKAMAPTEGLN1NAAALMNA | |
| SCHEMBL12080684 | 0.83 | DGKA (0.38) | HTR2CDGKAADRA2AADRA1AMAPT | |
| SCHEMBL10277563 | 0.83 | TSHR (0.38) | HTR2CGSTP1GSTM2DGKAADRA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121015962-A | Antibacterial anti-inflammatory regenerated marrow covering material and preparation method thereof | 广西医科大学 | 2025-11-28 | — | — | CN | disclosed |
| CN-105165823-A | Enhanced Retention Capabilities Through Methods Comprising Surface Treatment Of Functional Particulate Carrier Materials, And Functional Particulate Carrier Materials Made Therefrom | WORLD MINERALS INC | 2015-12-23 | — | — | CN | disclosed |
| US-8551332-B2 | Affinity particle and affinity separation method | SHISEIDO COMPANY, LTD. (JP) | 2013-10-08 | — | — | US | disclosed |
| EP-1759761-B1 | AFFINITY PARTICLE AND AFFINITY SEPARATION METHOD | SHISEIDO CO LTD (JP) | 2011-07-27 | — | — | EP | disclosed |
| EP-1750127-B1 | Method of affinity separation. | SHISEIDO CO LTD (JP) | 2011-07-20 | — | — | EP | disclosed |
| US-20100137133-A1 | Affinity Particle And Affinity Separation Method | SHISEIDO COMPANY, LTD. (JP) | 2010-06-03 | — | — | US | disclosed |
| US-20090321358-A1 | Affinity Particle And Method Of Affinity Separation | SHISEIDO COMPANY, LTD. (JP) | 2009-12-31 | — | — | US | disclosed |
| US-20090321357-A1 | Affinity Particle And Affinity Separation Method | SHISEIDO COMPANY, LTD. (JP) | 2009-12-31 | — | — | US | disclosed |
| US-20070241054-A1 | Affinity Particle And Method Of Affinity Separation | SHISEIDO COMPANY, LTD. (JP) | 2007-10-18 | — | — | US | disclosed |
| US-20070181503-A1 | Affinity particle and affinity separation method | SHISEIDO COMPANY, LTD. (JP) | 2007-08-09 | — | — | US | disclosed |
| EP-1759761-A1 | AFFINITY PARTICLE AND AFFINITY SEPARATION METHOD | SHISEIDO COMPANY, LTD. (JP) | 2007-03-07 | — | — | EP | disclosed |
| EP-1750127-A1 | AFFINITY PARTICLE AND METHOD OF AFFINITY SEPARATION | Shiseido Company, Limited (JP) | 2007-02-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090321357-A1 | Affinity Particle And Affinity Separation Method | FCGR1A, ACP1, FCGR3B | HTR2C 3792/4885GSTP1 658/4885GSTM2 2247/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.